Buildings and places in consumers’ perceptions of authenticity of corporate heritage brands: The Vista Alegre case study

While being a recent topic in the corporate marketing literature, corporate heritage brands are an acknowledged topic of research. A corporate heritage brand is a brand that embraces its own past in a relevant way, and that takes advantage of that past, in the present and to build a successful future. The purpose of this study is to understand the impact of buildings and places in consumers’ perceptions of authenticity in corporate heritage brands. This study was, therefore, designed within qualitative-inductive research, consisting of a single case study. The research process consisted of the analysis of 25 semi-structured interviews. This study’s contributions include geographical proximity of the spaces of corporate heritage brands to the residents, as a reason for consumers to visit the space while the region is part of the brand’s identity. Besides, by including stores from other brands in their space, corporate heritage brands can increase consumers’ chance to visit the space, while developing a cohesive image for consumers. Factors such as the aging of the buildings in the space of corporate heritage brands, as well as the representation of the company’s effort to provide good living conditions for the workers, influence consumers’ assessment of authenticity of the space

Questões sobre gênero : novos paradigmas e horizontes

info:eu-repo/semantics/publishedVersio

Construção de um programa promotor do envelhecimento ativo: o protótipo do programa REATIVA

info:eu-repo/semantics/publishedVersio

Guidelines for the management and treatment of periodic fever syndromes Cryopyrin-associated periodic syndromes (cryopyrinopathies – CAPS)

AbstractObjectiveTo establish guidelines based on cientific evidences for the management of cryopyrin associated periodic syndromes.Description of the evidence collection methodThe Guideline was prepared from 4 clinical questions that were structured through PICO (Patient, Intervention or indicator, Comparison and Outcome), to search in key primary scientific information databases. After defining the potential studies to support the recommendations, these were graduated considering their strength of evidence and grade of recommendation.Results1215 articles were retrieved and evaluated by title and abstract; from these, 42 articles were selected to support the recommendations.Recommendations1. The diagnosis of CAPS is based on clinical history and clinical manifestations, and later confirmed by genetic study. CAPS may manifest itself in three phenotypes: FCAS (mild form), MWS (intermediate form) and CINCA (severe form). Neurological, ophthalmic, otorhinolaryngological and radiological assessments may be highly valuable in distinguishing between syndromes; 2. The genetic diagnosis with NLRP3 gene analysis must be conducted in suspected cases of CAPS, i.e., individuals presenting before 20 years of age, recurrent episodes of inflammation expressed by a mild fever and urticaria; 3. Laboratory abnormalities include leukocytosis and elevated serum levels of inflammatory proteins; and 4. Targeted therapies directed against interleukin-1 lead to rapid remission of symptoms in most patients. However, there are important limitations on the long-term safety. None of the three anti-IL-1β inhibitors prevents progression of bone lesions

Profilaxia pré-exposição ao HIV (PrEP) como estratégia de prevenção combinada e sua eficácia clínica: Uma revisão integrada da Literatura.

This study aims to highlight the importance of Pre-Exposure Prophylaxis (PrEP) as an essential part of the combined HIV prevention strategy. To this end, an integrative review was conducted from June to September 2023, with research carried out in the SciELO and PubMed databases, using descriptors such as "PrEP/Pre-Exposure Prophylaxis", "HIV", "profilaxis/prophylaxis" and "effectiveness." The initial search resulted in 42 articles, which were subsequently subjected to rigorous selection criteria, resulting in the choice of 30 relevant articles. After applying the selection criteria, the 30 selected articles were subjected to a thorough reading by all members of the research team, aiming to collect effectiveness data. Seven large studies that evaluated the effectiveness of PrEP were identified and represented in a unified table, addressing the thematic categories of daily and on-demand pre-exposure prophylaxis. This made these studies easier to view and understand, providing a comprehensive view of PrEP effectiveness in different contexts. In summary, PrEP represents a significant advance in HIV prevention and plays a fundamental role in the fight against the epidemic. However, your success is intrinsically linked to awareness, education and ongoing support. Furthermore, PrEP must be integrated with other prevention strategies to optimize its impact in reducing the spread of HIV. The challenge now lies in ensuring equitable and effective access to PrEP, especially for vulnerable populations, in order to achieve goals related to ending the HIV epidemic. Consequently, PrEP plays a crucial role in the evolution of HIV prevention and the search for a future free from this epidemic.Este estudo tem como objetivo destacar a importância da Profilaxia Pré-Exposição (PrEP) como parte essencial da estratégia de prevenção combinada do HIV. Para isso, foi conduzida uma revisão integrativa no período de junho a setembro de 2023, com pesquisa realizada nas bases de dados SciELO e PubMed, utilizando descritores como "PrEP/Pre-Exposure Prophylaxis", "HIV", "profilaxia/ Prophylaxis" e "eficácia/effectiveness". A pesquisa inicial resultou em 42 artigos, que foram posteriormente submetidos a critérios de seleção rigorosos, resultando na escolha de 30 artigos relevantes. Após a aplicação dos critérios de seleção, os 30 artigos selecionados foram submetidos a uma leitura minuciosa por todos os membros da equipe de pesquisa, visando a coleta de dados de eficácia. Sete grandes estudos que avaliaram a eficácia da PrEP foram identificados e representados em uma tabela unificada, abordando as categorias temáticas de profilaxia pré-exposição de uso diário e sob demanda. Isso facilitou a visualização e compreensão desses estudos, fornecendo uma visão abrangente da eficácia da PrEP em diferentes contextos. Em resumo, a PrEP representa um avanço significativo na prevenção do HIV e desempenha um papel fundamental na luta contra a epidemia. No entanto, seu sucesso está intrinsecamente ligado à conscientização, educação e apoio contínuo. Além disso, a PrEP deve ser integrada a outras estratégias de prevenção para otimizar seu impacto na redução da disseminação do HIV. O desafio agora reside em garantir um acesso equitativo e eficaz à PrEP, especialmente para populações vulneráveis, a fim de alcançar as metas relacionadas ao término da epidemia de HIV. Consequentemente, a PrEP desempenha um papel crucial na evolução da prevenção do HIV e na busca por um futuro livre dessa epidemia

Identification of clusters of asthma control: A preliminary analysis of the inspirers studies

This work was funded by ERDF (European Regional Development Fund) through the operations: POCI- -01-0145-FEDER-029130 (“mINSPIRERS—mHealth to measure and improve adherence to medication in chronic obstructive respiratory diseases - generalisation and evaluation of gamification, peer support and advanced image processing technologies”) co-funded by the COMPETE2020 (Programa Operacional Competitividade e Internacionalização), Portugal 2020 and by Portuguese Funds through FCT (Fundação para a Ciência e a Tecnologia).© 2020, Sociedade Portuguesa de Alergologia e Imunologia Clinica. All rights reserved. Aims: To identify distinct asthma control clusters based on Control of Allergic Rhinitis and Asthma Test (CARAT) and to compare patients’ characteristics among these clusters. Methods: Adults and adolescents (≥13 years) with persistent asthma were recruited at 29 Portuguese hospital outpatient clinics, in the context of two observational studies of the INSPIRERS project. Demographic and clinical characteristics, adherence to inhaled medication, beliefs about inhaled medication, anxiety and depression, quality of life, and asthma control (CARAT, >24 good control) were collected. Hierarchical cluster analysis was performed using CARAT total score (CARAT-T). Results: 410 patients (68% adults), with a median (percentile 25–percentile 75) age of 28 (16-46) years, were analysed. Three clusters were identified [mean CARAT-T (min-max)]: cluster 1 [27(24-30)], cluster 2 [19(14-23)] and cluster 3 [10(2-13)]. Patients in cluster 1 (34%) were characterised by better asthma control, better quality of life, higher inhaler adherence and use of a single inhaler. Patients in clusters 2 (50%) and 3 (16%) had uncontrolled asthma, lower inhaler adherence, more symptoms of anxiety and depression and more than half had at least one exacerbation in the previous year. Further-more, patients in cluster 3 were predominantly female, had more unscheduled medical visits and more anxiety symp-toms, perceived a higher necessity of their prescribed inhalers but also higher levels of concern about taking these inhalers. There were no differences in age, body mass index, lung function, smoking status, hospital admissions or specialist physician follow-up time among the three clusters. Conclusion: An unsupervised method based on CARAT--T, identified 3 clusters of patients with distinct, clinically meaningful characteristics. The cluster with better asthma control had a cut-off similar to the established in the validation study of CARAT and an additional cut-off seems to distinguish more severe disease. Further research is necessary to validate the asthma control clusters identified.publishersversionpublishe

estudos artísticos

info:eu-repo/semantics/publishedVersio

Neurostimulation Combined With Cognitive Intervention in Alzheimer’s Disease (NeuroAD): Study Protocol of Double-Blind, Randomized, Factorial Clinical Trial

Despite advances in the treatment of Alzheimer’s disease (AD), there is currently no prospect of a cure, and evidence shows that multifactorial interventions can benefit patients. A promising therapeutic alternative is the use of transcranial direct current stimulation (tDCS) simultaneously with cognitive intervention. The combination of these non-pharmacological techniques is apparently a safe and accessible approach. This study protocol aims to compare the efficacy of tDCS and cognitive intervention in a double-blind, randomized and factorial clinical trial. One hundred participants diagnosed with mild-stage AD will be randomized to receive both tDCS and cognitive intervention, tDCS, cognitive intervention, or placebo. The treatment will last 8 weeks, with a 12-month follow-up. The primary outcome will be the improvement of global cognitive functions, evaluated by the AD Assessment Scale, cognitive subscale (ADAS-Cog). The secondary outcomes will include measures of functional, affective, and behavioral components, as well as a neurophysiological marker (Brain-derived neurotrophic factor, BDNF). This study will enable us to assess, both in the short and long term, whether tDCS is more effective than the placebo and to examine the effects of combined therapy (tDCS and cognitive intervention) and isolated treatments (tDCS vs. cognitive intervention) on patients with AD.Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT02772185—May 5, 2016

Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure (vol 9, e114548, 2014)

Hosp Univ Austral, Div Infect Dis Prevent & Infect Control Serv, Buenos Aires, DF, ArgentinaHosp Univ Austral, Microbiol Lab, Buenos Aires, DF, ArgentinaMonash Hlth, Monash Infect Dis, Clayton, Vic, AustraliaWollongong Hosp, Wollongong, NSW, AustraliaUniversidade Federal de São Paulo, Div Infect Dis, Lab Especial Microbiol Clin, São Paulo, BrazilHosp Israelita Albert Einstein, São Paulo, BrazilVirginia Commonwealth Univ, Med Ctr, Richmond, VA USAHosp Rim & Hipertensao, São Paulo, BrazilHosp Santa Casa Porto Alegre, Porto Alegre, RS, BrazilHosp Conceicao, Porto Alegre, RS, BrazilHosp Walter Cantidio, Fortaleza, Ceara, BrazilHosp Diadema, São Paulo, BrazilHosp Espanhol, Salvador, BA, BrazilHosp Clin Goiania, Goiania, Go, BrazilMt Sinai Hosp, Toronto, ON M5G 1X5, CanadaUniv Alberta, Div Infect Dis, Edmonton, AB, CanadaCairo Univ Kasr Ainy, Dar Al Fouad Hosp, Fac Med, Dept Clin Pathol, Cairo, EgyptHygeia Gen Hosp, Athens, GreeceUniv Tubingen Hosp, Internal Med, Div Infect Dis, Tubingen, GermanyTokyo Metropolitan Tama Med Ctr, Dept Infect Prevent, Tokyo, JapanAmphia Hosp Breda, Lab Microbiol & Infect Control, Breda, NetherlandsThammasat Univ Hosp, Div Infect Dis, Pathum Thani, ThailandSt John Hosp & Med Ctr, Infect Prevent & Control Dept, Grosse Pointe Woods, MI USAUniv Hosp Bern, Dept Infect Dis, CH-3010 Bern, SwitzerlandUniv Bern, Bern, SwitzerlandBarnes Jewish Hosp, St Louis, MO 63110 USAUniversidade Federal de São Paulo, Div Infect Dis, Lab Especial Microbiol Clin, São Paulo, BrazilWeb of Scienc